"A new brand image, to continue promoting the world of health"
For more information about our products, please contact: businessdevelopment@farmalider.com
For any other information, please contact: farmalider@farmalider.com
Identification, quantification, assessment and prevention
The Pharmacovigilance Department continuously monitors and analyses the information it receives on our medicines from different sources such as healthcare professionals and patients.
If you wish to report a suspected adverse reaction to any Farmalíder Group medicine please contact us and our Pharmacovigilance department will collect this information and contact you as soon as possible.
In compliance with current legislation on the protection of personal data, we inform you that your personal data will be treated confidentially for the purpose of "Managing adverse reactions/special situations of medicines and incidents/clinical events regarding FARMALIDER products.
For more information about our Personal Data Protection policy, please see our Privacy Policy in the field of pharmacovigilance.
